Pérez Pérez A., Ortega Martínez de Victoria E., Arrieta Blanco F., Caixàs Pedragós A., Santos Mazo E., Fernández-Catalina P., Martínez-Hervas S., López-Medina J.A., Suárez-Gutiérrez L., Urgeles Planelles J.R., Gatell Menchén S., Tinahones Madueño F.. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO). Endocrinologia Diabetes y Nutricion. 2022; 69(7)DOI:10.1016/j.endinu.2021.07.009. PMID:35995680. IF:1.900(Q4/9D).

Tomic D., Morton J.I., Chen L., Salim A., Gregg E.W., Pavkov M.E., Arffman M., Balicer R., Baviera M., Boersma-van Dam E., Brinks R., Carstensen B., Chan J.C.N., Cheng Y.J., Fosse-Edorh S., Fuentes S., Gardiner H., Gulseth H.L., Gurevicius R., Ha K.H., Hoyer A., Jermendy G., Kautzky-Willer A., Keskimäki I., Kim D.J., Kiss Z., Klimek P., Leventer-Roberts M., Lin C.-Y., Lopez-Doriga Ruiz P., Luk A.O.Y., Ma S., Mata-Cases M., Mauricio D., McGurnaghan S., Imamura T., Paul S.K., Peeters A., Pildava S., Porath A., Robitaille C., Roncaglioni M.C., Sugiyama T., Wang K.-L., Wild S.H., Yekutiel N., Shaw J.E., Magliano D.J.. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes & Endocrinology. 2022; 10(11)DOI:10.1016/S2213-8587(22)00252-2. PMID:36183736. IF:44.500(Q1/1D).

van Haalen F.M., Kaya M., Pelsma I.C.M., Cannegieter S.C., Huisman M.V., van Vlijmen B.J.M., Feelders R.A., Stochholm K., Fliers E., Castinetti F., Brue T., Bertherat J., Scaroni C., Colao A., Giordano R., Druce M.R., Beckers A., Spranger J., Driessens N., Maiter D., Feldt-Rasmussen U., Feelders R., Webb S.M., Dattani M., Husebye E., Zilaitiene B., Gaztambide S., Gatto F., Ferone D., Persani L., Chiodini I., Höybye C., Pereira A.M., Biermasz N.R., Klok F.A., Dekkers O.M., Meijer O.C., Reincke M., Vila G., Perry C., Heck A., Stancampiano M.R., van de Ven A., Johannsson G., Ragnarsson O., Tóth M., Volke V., Toumba M., Canu L., Vojtková J., Al-Mrayat M., Fassnacht M., Detomas M., Karavitaki N., van der Klauw M.M., Groselj U., Elenkova A., Unuane D.. Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02320-x. PMID:35505430. IF:3.700(Q2/4D).

Rivero-Sanchez, L, Gavric, A, Herrero, J, Remedios, D, Alvarez, V, Albeniz, E, Gordillo, J, Puig, I, Lopez-Vicente, J, Huerta, A, Lopez-Ceron, M, Salces, I, Penas, B, Parejo, S, Rodriguez, E, Herraiz, M, Carretero, C, Gimeno-Garcia, AZ, Saperas, E, Alvarez, C, Arnau-Collell, C, Ortiz, O, Sanchez, A, Jung, G, Balaguer, F, Pellise, M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. ENDOSCOPY. 2022; 54(01)DOI:10.1055/a-1328-5405. PMID:33271604. IF:9.300(Q1/1D).

Batista, G, Marin-Jimenez, I, Fores, A, Garcia-Planella, E, Arguelles-Arias, F, Tagarro, I, Fernandez-Nistal, A, Montoto, C, Aparicio, J, Aguas, M, Santos-Fernandez, J, Bosca-Watts, MM, Ferreiro-Iglesias, R, Merino, O, Aldeguer, X, Corttes, X, Sicilia, B, Mesonero, F, Barreiro-de Acosta, M. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study. DIGESTIVE AND LIVER DISEASE. 2022; 54(1)DOI:10.1016/j.dld.2021.06.005. PMID:34244110. IF:4.500(Q2/4D).

Zabana, Y, Marin-Jimenez, I, Rodriguez-Lago, I, Vera, I, Martin-Arranz, MD, Guerra, I, Gisbert, JP, Mesonero, F, Benitez, O, Taxonera, C, Ponferrada-Diaz, A, Piqueras, M, Lucendo, AJ, Caballol, B, Manosa, M, Martinez-Montiel, P, Bosca-Watts, M, Gordillo, J, Bujanda, L, Mancenido, N, Martinez-Perez, T, Lopez, A, Rodriguez-Gutierrez, C, Garcia-Lopez, S, Vega, P, Rivero, M, Melcarne, L, Calvo, M, Iborra, M, de-Acosta, MB, Sicilia, B, Barrio, J, Perez, JL, Busquets, D, Perez-Martinez, I, Navarro-Llavat, M, Hernandez, V, Argueelles-Arias, F, Esteso, FR, Meijide, S, Ramos, L, Gomollon, F, Munoz, F, Suris, G, de Zarate, JO, Huguet, JM, Llao, J, Garcia-Sepulcre, MF, Sierra, M, Dura, M, Estrecha, S, Coronel, AF, Hinojosa, E, Olivan, L, Iglesias, E, Gutierrez, A, Varela, P, Rull, N, Gilabert, P, Hernandez-Camba, A, Brotons, A, Ginard, D, Sese, E, Carpio, D, Aceituno, M, Cabriada, JL, Gonzalez-Lama, Y, Jimenez, L, Chaparro, M, Roman, ALS, Alba, C, Plaza-Santos, R, Mena, R, Tamarit-Sebastian, S, Ricart, E, Calafat, M, Olivares, S, Navarro, P, Bertoletti, F, Alonso-Galan, H, Pajares, R, Olcina, P, Manzano, P, Domenech, E, Esteve, M. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. Journal of Clinical Medicine. 2022; 11(2)DOI:10.3390/jcm11020421. PMID:35054116. IF:3.900(Q2/4D).

Semmler G., Lens S., Meyer E.L., Baiges A., Alvardo-Tapias E., Llop E., Tellez L., Schwabl P., Mauro E., Escudé L., Díez C., Ibañez-Samaniego L., Puente Á., Fortea J.I., Abadía M., Zanetto A., Conthe A., Hernandez-Évole H., Luzko Scheid I.S., Jia J., Yoshiji H., Francque S.M., Tsochatzis E.A., Russo F.P., Crespo G., Forns X., Bañares R., Villanueva C., Hernández-Gea V., Reiberger T., Bosch J., García Pagán J.C., Mandorfer M.. Non-invasive tests for clinically significant portal hypertension after HCV cure. JOURNAL OF HEPATOLOGY. 2022; 77(6)DOI:10.1016/j.jhep.2022.08.025. PMID:36063968. IF:25.700(Q1/1D).

Iborra M., Moret I., Busó E., García-Giménez J.L., Ricart E., Gisbert J.P., Cabré E., Esteve M., Márquez-Mosquera L., García-Planella E., Guardiola J., Pallardó F.V., Serena C., Algaba-Chueca F., Domenech E., Nos P., Beltrán B.. The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(24)DOI:10.3390/ijms232415881. PMID:36555526. IF:5.600(Q1/3D).